FIELD: pharmaceutical industry, pharmacy.
SUBSTANCE: invention relates to producing interferon-containing suppositories. Interferon-containing suppository comprises a fatty base, emulsifier and human lyophilized interferon purified from low-molecular and high-molecular components of the definite antiviral activity. Mixture of mono-, di- and triglycerides and saturated fatty acids from coconut oil and palm oil of sort "Vitepsol" H-15 and W-35 taken in equal ratio are used as a fatty base. Distilled monoglycerides taken in the definite ratio are used as an emulsifier. Above describes suppositories retain specific activity and effectiveness in treatment of viral and bacterial diseases for a long time and show stability against mechanical effects.
EFFECT: improved and valuable properties of suppository.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUPPOSITORIES WITH SODIUM AMINODIHYDROPHTHALAZINEDIONE | 2020 |
|
RU2760262C1 |
| OINTMENT WITH HUMAN LEUKOCYTIC INTERFERON "INTERON" | 1997 |
|
RU2141819C1 |
| VAGINAL SUPPOSITORY FOR TREATING INFECTIOUS-INFLAMMATORY VAGINAL DISEASES, AND A METHOD FOR PREPARING | 2019 |
|
RU2695995C1 |
| RECTAL SUPPOSITORIES AND METHOD FOR PREPARATION THEREOF (OPTIONS) | 2017 |
|
RU2674029C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATE DISEASES (VERSIONS) | 2009 |
|
RU2430733C2 |
| RECTAL SUPPOSITORY MEDICINAL PRODUCT AND METHOD FOR ITS PREPARATION | 2018 |
|
RU2689320C1 |
| VAGINAL SUPPOSITORY SHOWING ANTIMICROBIAL EFFECT | 1997 |
|
RU2115412C1 |
| COMPLEX ACTION MEDICATION AND METHOD OF ITS PRODUCTION | 2012 |
|
RU2519553C1 |
| CALCIUM GLUCONATE NANOSUBSTANCE SUPPOSITORIES FOR TREATING DISEASES RELATED TO CALCIUM DEFICIENCY (VERSIONS) | 2012 |
|
RU2511649C1 |
| MEDICAL PRODUCT AND MEDICINAL COMPOSITION FOR MANUFACTURING THEREOF | 2008 |
|
RU2372933C1 |
